SWP
SRNE

Stratos Wealth Partners’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Stratos Wealth Partners’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,090
Closed -$26K – 1249
2022
Q2 		$26K Buy
13,090
+15
+0.1% +$26 ﹤0.01% 1177
2022
Q1 		$30K Buy
+13,075
New +$40.8K ﹤0.01% 1253
2021
Q4 		– Sell
-16,060
Closed -$123K – 1312
2021
Q3 		$123K Sell
16,060
-13,720
-46% -$116K ﹤0.01% 1136
2021
Q2 		$289K Sell
29,780
-175
-0.6% -$1.39K 0.01% 988
2021
Q1 		$248K Sell
29,955
-9,948
-25% -$105K 0.01% 960
2020
Q4 		$272K Buy
39,903
+29,677
+290% +$238K 0.01% 885
2020
Q3 		$114K Buy
+10,226
New +$93.6K ﹤0.01% 964

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return